ANTIBODY DRUG CONJUGATE COMPRISING NMT INHIBITOR AND ITS USE Application WO-2024052684-A1 World Intellectual Property Organisation (WIPO) 14 Mar 2024
Heterocyclic acyl hydrazone linkers, methods and uses thereof Grant US-11850287-B2 United States of America 26 Dec 2023
ANTIBODY-DRUG CONJUGATES AND THEIR USES Application WO-2023170247-A1 World Intellectual Property Organisation (WIPO) 14 Sep 2023
IMPROVED ANTIBODY-PAYLOAD CONJUGATES (APCS) PREPARED BY SITE-SPECIFIC CONJUGATION… Application WO-2023094525-A1 World Intellectual Property Organisation (WIPO) 01 Jun 2023
IMPROVED ANTIBODY-PAYLOAD CONJUGATES (APCS) PREPARED BY SITE-SPECIFIC CONJUGATION… Application EP-4186529-A1 European Patent Office 31 May 2023
IL-2/IL-15RBETAGAMMA AGONIST COMBINATION WITH ANTIBODY-DRUG CONJUGATES FOR TREATING CANCER Application WO-2023017191-A1 World Intellectual Property Organisation (WIPO) 16 Feb 2023
HER2 TARGETING FC ANTIGEN BINDING FRAGMENT-DRUG CONJUGATES Application WO-2022233718-A2 World Intellectual Property Organisation (WIPO) 10 Nov 2022
DRUG ANTIBODY CONJUGATES Application WO-2021214126-A1 World Intellectual Property Organisation (WIPO) 28 Oct 2021
METHODS AND COMPOSITIONS FOR TARGETING DISEASE RELATED CELL SURFACE RECEPTORS USING… Application US-20210236667-A1 United States of America 05 Aug 2021
PHARMACEUTICAL COMPOSITION FOR CANCER TREATMENT AND/OR PREVENTION Application US-20200054762-A1 United States of America 20 Feb 2020